Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by 2for1spliton May 17, 2018 4:13pm

93 Views

Post# 28048516

RE:RE:RE:TODAYS volume 5.45 million so far

I like this part in particular:

If this newly discovered characteristic of the Theralase PDCs can be replicated in humans and demonstrate the same efficacy that it has in small animals, then the implications to the war on cancer could be immense. I look forward to furthering this preclinical work to the clinical stage to validate its efficacy in humans.”

Bullboard Posts

How a junior advances one of the largest undeveloped diamond projects